Athira Pharma

$0.00 (0.00%) Today
-$0.12 (-1.02%) As of 11:12 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Athira Pharma and other ETFs, options, and stocks.

About ATHA

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline include ATH-1017, ATH-1019/20, and ATH-1018.

CEO
Mark J. Litton
Employees
22
Headquarters
Bothell, Washington
Founded
2011

ATHA Key Statistics

Market Cap
438.60M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
627.10K
High Today
$12.08
Low Today
$11.56
Open Price
$11.80
Volume
608.37K
52 Week High
$34.79
52 Week Low
$8.88

ATHA Earnings

-$1.12
-$0.75
-$0.37
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure